These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6671796)

  • 21. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
    Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
    Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial drugs used in the management of anaerobic infections in children.
    Brook I
    Drugs; 1983 Dec; 26(6):520-9. PubMed ID: 6360636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting the choice of antibiotics in mixed infections.
    Tally FP
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():87-100. PubMed ID: 3209540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobials therapy of anaerobic infections.
    Brook I
    J Chemother; 2016 Jun; 28(3):143-50. PubMed ID: 26365224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
    Ginunas VJ; Canawati HN; Sapico FL
    Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of a 'susceptible' Escherichia coli to metronidazole therapy: an investigation using experimental subcutaneous abscesses.
    Reznikov M; Hakendorf PH; Matthews DB
    Chemotherapy; 1985; 31(1):50-4. PubMed ID: 3882353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of anaerobic bacteria in peritonsillar abscesses].
    Zagólski O; Gajda M
    Pol Merkur Lekarski; 2008 Feb; 24(140):146-8. PubMed ID: 18634272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiology of polymicrobial abscesses and implications for therapy.
    Brook I
    J Antimicrob Chemother; 2002 Dec; 50(6):805-10. PubMed ID: 12460997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative bacteriology of acute dento-alveolar abscesses.
    Lewis MA; MacFarlane TW; McGowan DA
    J Med Microbiol; 1986 Mar; 21(2):101-4. PubMed ID: 2869147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bacteriology of intra-abdominal abscesses in Nigerian children.
    Ako-Nai AK; Adejuyigbe O; Ebri DA; Ajayi PA
    J Trop Pediatr; 1990 Aug; 36(4):159-61. PubMed ID: 2213978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaerobic bacterial infections and response to treatment in dogs and cats: 36 cases (1983-1985).
    Dow SW; Jones RL; Adney WS
    J Am Vet Med Assoc; 1986 Oct; 189(8):930-4. PubMed ID: 2876976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of clindamycin, metronidazole, and penicillin for the treatment of experimental infections in mice caused by beta-lactamase-producing Bacteroides intermedius.
    Cockerill FR; Rosenblatt JE; Lee DT; Gay JD
    Diagn Microbiol Infect Dis; 1986 May; 5(1):25-30. PubMed ID: 3486740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
    Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
    J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergy between spiramycin and metronidazole in the treatment of polymicrobial infections.
    Brook I
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():77-85. PubMed ID: 3141350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.